ONCO3 Stock Overview
Oncoclínicas do Brasil Serviços Médicos S.A.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Oncoclínicas do Brasil Serviços Médicos S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$11.48 |
| 52 Week High | R$12.77 |
| 52 Week Low | R$5.39 |
| Beta | 1.13 |
| 1 Month Change | -9.03% |
| 3 Month Change | 11.56% |
| 1 Year Change | 79.66% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -39.93% |
Recent News & Updates
Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?
Sep 11
Shareholder Returns
| ONCO3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 2.6% | 1.1% | 0.2% |
| 1Y | 79.7% | -21.3% | -2.4% |
Return vs Industry: ONCO3 exceeded the BR Healthcare industry which returned -21.3% over the past year.
Return vs Market: ONCO3 exceeded the BR Market which returned -2.4% over the past year.
Price Volatility
| ONCO3 volatility | |
|---|---|
| ONCO3 Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.5% |
Stable Share Price: ONCO3 is not significantly more volatile than the rest of BR stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ONCO3's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Bruno Ferrari | https://www.grupooncoclinicas.com |
Oncoclínicas do Brasil Serviços Médicos S.A. provides medical services focused on clinical oncology and radiotherapy in Latin America. It offers services in the areas of chemotherapy, radiotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter heparinization, non-oncological infusions, laser therapy, myelogram - bone marrow biopsy, continuous care, and precision medicine. The company was founded in 2010 and is based in São Paulo, Brazil.
Oncoclínicas do Brasil Serviços Médicos S.A. Fundamentals Summary
| ONCO3 fundamental statistics | |
|---|---|
| Market Cap | R$5.83b |
| Earnings (TTM) | R$145.14m |
| Revenue (TTM) | R$5.03b |
40.2x
P/E Ratio1.2x
P/S RatioIs ONCO3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ONCO3 income statement (TTM) | |
|---|---|
| Revenue | R$5.03b |
| Cost of Revenue | R$3.23b |
| Gross Profit | R$1.81b |
| Other Expenses | R$1.66b |
| Earnings | R$145.14m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 13, 2023
| Earnings per share (EPS) | 0.29 |
| Gross Margin | 35.87% |
| Net Profit Margin | 2.88% |
| Debt/Equity Ratio | 117.9% |
How did ONCO3 perform over the long term?
See historical performance and comparison